fda crackdown on compounded semaglutide The announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new (Wegovy) weight-loss pill from the Popular weight-loss drugs, including Ozempic,

With obesity impacting the health and welfare of 42% of adults and costing the U.S

Notably, NP toxicity remains a major obstacle for future applications

Heres how the evidence stacks up when we look at effectiveness by goal: Cognitive performance: Citicoline and alpha-glycerophosphocholine (alpha-GPC) are choline compounds that appear to cross the bloodbrain barrier and support acetylcholine, which is critical for brain function.4 5 6 Citicoline has the strongest trial evidence at 250-500mg/day, while alpha-GPC shows promise but with fewer studies.7 8 Athletic performance: Small preliminary trials suggest alpha-GPC may enhance lower-body power at 600mg/day and support post-exercise recovery at 1,000mg/day.9 10 Liver health: Phosphatidylcholine (PC) is a common supplemental form of choline that helps package and export fats from the liver

Antibiotics are not needed routinely and should not be used without strong evidence for need and knowing which drug the bacteria are sensitive to

Squinting at faint markings is how doses get misread

BPC-157, short for Body Protection Compound 157, is a synthetic peptide consisting of 15 amino acids